Literature DB >> 1234485

Effect of long-term phenothiazine treatment on drug metabolism.

T Kolakowska, M Franklin, B Alapin.   

Abstract

1 The half-life of plasma antipyrine was measured in twelve chronic schizophrenic patients during long-term phenothiazine treatment and again following 4-5 weeks on placebo. 2 The mean antipyrine half-life was low during phenothiazine administration (6.1 +/- 4.2 h), rising after withdrawal of drugs to the range reported for untreated subjects by other authors (9.5 +/- 4.2 h). The prolongation of antipyrine half-life following the drug-free period occurred in nine of twelve subjects and the difference was significant for the group at P less than 0.05. 3 The finding suggests that prolonged administration of phenothiazines stimulates the rate of drug metabolism.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1234485      PMCID: PMC1402496          DOI: 10.1111/j.1365-2125.1975.tb00467.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  17 in total

1.  Induction of increased meprobamate metabolism in rats pretreated with some neurotropic drugs.

Authors:  R KATO; P VASSANELLI
Journal:  Biochem Pharmacol       Date:  1962-08       Impact factor: 5.858

2.  Perazine, chlorpromazine and imipramine as inducers of microsomal drug metabolism.

Authors:  U Breyer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

3.  Comparative drug elimination capacity in man-glutethimide, amobarbital, antipyrine, and sulfinpyrazone.

Authors:  D Kadar; T Inaba; L Endrenyi; G E Johnson; W Kalow
Journal:  Clin Pharmacol Ther       Date:  1973 Jul-Aug       Impact factor: 6.875

4.  Stimulation of drug metabolism in man by tricyclic antidepressants.

Authors:  K O'Malley; M Browning; I Stevenson; M J Turnbull
Journal:  Eur J Clin Pharmacol       Date:  1973-08       Impact factor: 2.953

5.  Physiologic and clinical effects of chlorpromazine and their relationship to plasma level.

Authors:  G Sakalis; S H Curry; G P Mould; M H Lader
Journal:  Clin Pharmacol Ther       Date:  1972 Nov-Dec       Impact factor: 6.875

6.  Drug-metabolizing capacity in states of drug dependence and withdrawal.

Authors:  B Ballinger; M Browning; K O'Malley; I H Stevenson
Journal:  Br J Pharmacol       Date:  1972-08       Impact factor: 8.739

7.  Impairment of drug metabolism in man by allopurinol and nortriptyline.

Authors:  E S Vesell; G T Passananti; F E Greene
Journal:  N Engl J Med       Date:  1970-12-31       Impact factor: 91.245

8.  Effects of various centrally active drugs on hepatic microsomal enzymes: a comparative study.

Authors:  D M Valerino; E S Vesell; A O Johnson; K C Aurori
Journal:  Drug Metab Dispos       Date:  1973 Sep-Oct       Impact factor: 3.922

9.  Genetic control of the phenobarbital-induced shortening of plasma antipyrine half-lives in man.

Authors:  E S Vesell; J G Page
Journal:  J Clin Invest       Date:  1969-12       Impact factor: 14.808

10.  Drug interaction: inhibitory effect of neuroleptics on metabolism of tricyclic antidepressants in man.

Authors:  L F Gram; K F Overo
Journal:  Br Med J       Date:  1972-02-19
View more
  2 in total

1.  Induction of drug-metabolizing enzymes by tricyclic antidepressants in human liver: characterization and partial resolution of cytochromes P-450.

Authors:  T Cresteil; C Célier; P Kremers; J P Flinois; P Beaune; J P Leroux
Journal:  Br J Clin Pharmacol       Date:  1983-12       Impact factor: 4.335

Review 2.  Drug interactions and clinical pharmacokinetics.

Authors:  M B Kristensen
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.